Pedro Barbosa
PAST
| Acronym | Title | Funding Entity | Start Date | End Date |
|---|---|---|---|---|
| CAMELOT | Autonomic platform for Machine Learning using anonymized data | P2020 | 01/07/2020 | 01/01/2023 |
Pedro Barbosa, Rosina Savisaar, Alcides Fonseca. Semantically Rich Local Dataset Generation for Explainable AI in Genomics. In Proceedings of the Genetic and Evolutionary Computation Conference. ACM, 2024 [Biblios]
Pedro Barbosa, Rosina Savisaar, Maria Carmo-Fonseca, Alcides Fonseca. Computational prediction of human deep intronic variation. GigaScience, 12, Oxford University Press (OUP), 2022 [Biblios]
Guilherme Espada, Leon Ingelse, Paulo Canelas, Pedro Barbosa, Alcides Fonseca. Data Types as a More Ergonomic Frontend for Grammar-Guided Genetic Programming. In Proceedings of the 21st ACM SIGPLAN International Conference on Generative Programming: Concepts and Experiences. ACM, 2022 [Biblios]
Pedro Barbosa, Marta Ribeiro, Maria Carmo-Fonseca, Alcides Fonseca. Clinical significance of genetic variation in hypertrophic cardiomyopathy: comparison of computational tools to prioritize missense variants. Frontiers in Cardiovascular Medicine, 9, Frontiers Media SA, 2022 [Biblios]
Sónia Matos, Paulo Bernardo, Susana Esteves, Aida Botelho de Sousa, Marcos Lemos, Patrícia Ribeiro, Madalena Silva, Albertina Nunes, Joana Lobato, Maria de Jesus Frade, Maria Gomes da Silva, Sérgio Chacim, José Mariz, Graça Esteves, João Raposo, Ana Espadana, José Carda, Pedro Barbosa, Vânia Martins, Maria Carmo-Fonseca, Joana Desterro. Screening a Targeted Panel of Genes by Next-Generation Sequencing Improves Risk Stratification in Real World Patients with Acute Myeloid Leukemia. Cancers, 14(13), MDPI AG, 2022 [Biblios]
Luis R. Lopes, Pedro Barbosa, Mario Torrado, Ellie Quinn, Ana Merino, Juan Pablo Ochoa, Joanna Jager, Marta Futema, Maria Carmo-Fonseca, Lorenzo Monserrat, Petros Syrris, Perry M. Elliott. Cryptic Splice-Altering Variants in MYBPC3 Are a Prevalent Cause of Hypertrophic Cardiomyopathy. Circulation: Genomic and Precision Medicine, 13(3), Ovid Technologies (Wolters Kluwer Health), 2020 [Biblios]